Sign in Subscribe
COVID-19

Genetic Analysis Reveals New Insights into COVID-19 Vaccine-Associated Glomerulopathy

Strategic Insights

— 1 min read

Research conducted by the Taipei Tzu Chi Hospital in Taipei, Taiwan, has made significant findings regarding the emergence of glomerular diseases following COVID-19 vaccination, particularly with mRNA vaccines. A 51-year-old female patient developed C3 glomerulopathy after receiving her third dose of the mRNA-1273 (Moderna) COVID-19 vaccine. Through comprehensive whole-genome exome sequencing, researchers identified a missense mutation in the SLC12A3 gene and other genetic variations, which may provide insights into the molecular mechanisms underlying vaccine-associated glomerulopathies.

Key Takeaways:

  • The study highlighted the emergence of glomerular diseases following COVID-19 vaccination, particularly with mRNA vaccines.
  • The genetic analysis of a 51-year-old female patient revealed a missense mutation in the SLC12A3 gene and other genetic variations.
  • The mutations identified through whole-genome exome analysis contributed to a deeper understanding of the molecular mechanisms potentially triggered by mRNA vaccines.
  • The research concluded that exploring genetic predispositions is crucial when encountering adverse reactions to mRNA vaccines, particularly those affecting the complement pathway and glomerulopathies.
  • The study involved a unique instance of C3 glomerulopathy following mRNA-1273 (Moderna) vaccination.
  • Financial support for the research came from the Taipei Tzu Chi Medical Foundation.
  • The research was peer-reviewed and published in the Clinical Nephrology journal in 2025.

Statistics:

  • The study involved a 51-year-old female patient.
  • The patient received her third dose of the mRNA-1273 (Moderna) COVID-19 vaccine.
  • The genetic analysis revealed a missense mutation in the SLC12A3 gene and other genetic variations.
  • The research concluded that exploring genetic predispositions is crucial when encountering adverse reactions to mRNA vaccines.
  • The study focused on the genetic mutations identified through whole-genome exome analysis.
  • The research was supported by the Taipei Tzu Chi Medical Foundation.

Sources:

  • NewsRx. Findings from Taipei Tzu Chi Hospital Yields New Data on COVID-19 [C3 Glomerulopathy and Acute Kidney Injury After Mrna-1273 (Moderna) Covid-19 Vaccine and Genetical Analysis]. Genomics & Genetics Weekly. July 4, 2025; p 53.
  • Clinical Nephrology. C3 Glomerulopathy and Acute Kidney Injury After Mrna-1273 (Moderna) Covid-19 Vaccine and Genetical Analysis. Dustri-verlag Dr Karl Feistle, Bahnhofstrasse 9 Postfach 49, D-82032 Deisenhofen-Muenchen, Germany.

Read more